NCT01382641

Brief Summary

The doctors participating in this study are looking to show improved vision with the HOYA AF-1 aspheric intraocular lens after cataract surgery. They will also study the use of Revital Vision (neuro-sensory testing) in providing the highest potential for improved vision.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for phase_4

Timeline
Completed

Started Sep 2010

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2010

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

June 3, 2011

Completed
24 days until next milestone

First Posted

Study publicly available on registry

June 27, 2011

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2011

Completed
Last Updated

October 6, 2011

Status Verified

October 1, 2011

Enrollment Period

1.2 years

First QC Date

June 3, 2011

Last Update Submit

October 5, 2011

Conditions

Keywords

Cataract surgery

Outcome Measures

Primary Outcomes (2)

  • Measuring Ocular Dominance

    3 months

  • Overall post surgical outcomes

    3 months

Secondary Outcomes (1)

  • Measuring visual acuities

    3 months

Study Arms (2)

Hoya AF-1 IOL

OTHER
Device: Hoya AF-1 IOL

Revital Vision

OTHER
Device: Revital vision

Interventions

The patients will be assessed for three months

Hoya AF-1 IOL

The patients will be assessed for three months.

Revital Vision

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients must desire to pursue some type of mono-vision fit, mono-vision lasik, or mono-vision cataract surgery with lens implant.
  • Patients must be candidates for intraocular lens implantation for the correction of aphakia following extracapsular cataract extraction by phaco-emulsification.
  • Patients must be candidates for bilateral implantation and desiring post-operative spectacle independence through targeted mono-vision.
  • Patients must have less than 1.50 diopters of corneal astigmatism
  • Patients must have the potential for best corrected visual acuity of 20/30 or better in each eye.
  • Patients must have the mental capacity to cooperate when undergoing a detailed postoperative refractive examination.
  • Patients must be an adult.
  • Patients must provide written informed consent for cataract surgery.
  • Patients must be willing and able to return for scheduled follow-up examinations for a period of 3 months (post-second eye) post-operatively.
  • Patients must be willing and able to provide feedback to various survey questions regarding overall satisfaction and ease of adaptation to mono-vision and range of vision, etc.

You may not qualify if:

  • Patients with 1.50 diopters or more of corneal astigmatism
  • Patients requiring a lens power less than 6 D or greater than 30 D
  • Patients with any anterior segment pathology (chronic uveitis, iritis, iridocyclitis, rubeosis iridis, corneal dystrophy or corneal degeneration, tear film deficiency, poor pupil dilation, etc.).
  • Patients with uncontrolled glaucoma or who require current treatment for glaucoma, or with visual field loss as a result of glaucoma.
  • Patients with retinal pathology or a history of retinal detachment.
  • Patients with proliferative diabetic retinopathy, macular degeneration, or other degenerative visual disorders.
  • Patients with a history of previous ocular surgery including corneal refractive surgery.
  • Patients with congenital bilateral cataracts.
  • Patients with marked microphthalmos or aniridia.
  • Patients who have only one functioning eye.
  • Patients who do not have the potential for visual acuity of 20/30 or better in each eye.
  • Patients lacking intact binocular vision.
  • Patients who do not have an intact capsulorhexis and posterior capsular bag at the time of cataract removal and lens implantation.
  • Patients who have incomplete or damaged zonules, or who have zonular rupture during cataract removal.
  • Patients with pupils greater than 7mm

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

McDonald Eye Associates, PA

Fayetteville, Arkansas, United States

Location

MeSH Terms

Conditions

Cataract

Condition Hierarchy (Ancestors)

Lens DiseasesEye Diseases

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

June 3, 2011

First Posted

June 27, 2011

Study Start

September 1, 2010

Primary Completion

December 1, 2011

Study Completion

December 1, 2011

Last Updated

October 6, 2011

Record last verified: 2011-10

Locations